logo

Mallinckrodt Plc (MNK)



Trade MNK now with
  Date
  Headline
12/12/2018 6:45:51 AM Mallinckrodt's SpecGx Gets FDA CRL For Abuse-Deterrent, Immediate-Release Reformulation Of Roxicodone
12/6/2018 6:02:00 AM Mallinckrodt Plans Spin-Off Of Specialty Generics Business To Shareholders
11/9/2018 8:11:28 AM Mallinckrodt Reports Results Of Pooled Analysis Of Terlipressin Clinical Trial Data In HRS-1 Patients
11/6/2018 6:07:48 AM Mallinckrodt Q3 GAAP EPS From Cont Ops $1.21 Vs $0.55 Last Year
10/26/2018 6:48:12 AM Mallinckrodt Says First Patient Screened In Phase 4 Trial Of H.P. Acthar Gel
10/22/2018 6:50:35 AM Mallinckrodt Presents Data On H.P. Acthar Gel In Rheumatoid Arthritis At ACR/ARHP Annual Meeting
10/15/2018 6:48:53 AM Stratatech Awarded About $26 Mln In Additional Project BioShield Funding By BARDA
10/8/2018 6:46:48 AM Mallinckrodt Seeks Approval Of NDA For MNK-812 Through 505(b)2 Regulatory Pathway
8/23/2018 6:45:53 AM Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
8/22/2018 6:49:55 AM Mallinckrodt Confirms Complete Response Letter From FDA Related To NDA For Stannsoporfin
8/7/2018 6:06:06 AM Mallinckrodt Q2 Adjusted EPS $1.78 Vs $1.36 Last Year